Femme et Homme | 18 ans et plus
- | Pays :
- France
- | Organes :
- Sein
- | Spécialités :
- Thérapies Ciblées
Extrait
A phase Ib/II, open-label study of the safety, tolerability, and efficacy of in combination with pertuzumab administered intravenously to patients with HER2-positive locally advanced or metastatic breast cancer who have previously received trastuzumab.
Extrait Scientifique
en cours d'intégration;